• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估 Toll 样受体 3(c.1377C/T)和 9(G2848A)基因多态性与宫颈癌易感性的关系。

Evaluation of Toll-like receptors 3 (c.1377C/T) and 9 (G2848A) gene polymorphisms in cervical cancer susceptibility.

机构信息

Department of Genetics, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India.

出版信息

Mol Biol Rep. 2011 Oct;38(7):4715-21. doi: 10.1007/s11033-010-0607-z. Epub 2010 Dec 5.

DOI:10.1007/s11033-010-0607-z
PMID:21132533
Abstract

Cervical cancer is emerging as a leading cause of morbidity and mortality in women worldwide. Toll-like Receptor (TLR) gene polymorphisms may contribute to subsequent inter-individual variability in cancer susceptibility. The present study aimed to identify the role of TLR 3 (c.1377C/T) [rs3775290] and TLR 9 (G2848A) [rs352140] gene polymorphisms in the risk of developing cervical cancer in North India. Peripheral blood samples were collected from 200 histopathologically confirmed cervical cancer patients from North India and 200 unrelated, cancer-free, age-matched healthy female controls of similar ethnicity. Genomic DNA was extracted using the salting-out method, and genotyped for TLR 3 and TLR 9 using polymerase chain reaction-based restriction fragment length polymorphism (PCR-RFLP). Our data demonstrated a lack of association between TLR 3 (c.1377C/T) and TLR 9 (G2848A) gene polymorphisms and the risk of developing cervical cancer. TLR 3 CT + TT was marginally associated (P = 0.061; age-adjusted OR = 1.46; 95% CI = 0.98-2.16) with cervical cancer susceptibility. The AA genotype of TLR 9 showed borderline significance (P = 0.053) conferring a marginal increased risk (OR = 2.63, 95%CI = 0.99-7.01) for advanced cancer stages (III + IV). Further, TLR 3 and 9 polymorphisms did not have a significant role in modulation of risk due to tobacco usage in cervical cancer patients. Our study suggests only marginal role of TLR 3 and 9 gene polymorphisms in cervical cancer susceptibility in North India; however, future studies in ethnically diverse populations may provide a more comprehensive involvement of innate immunity in cervical cancer etiology in women worldwide.

摘要

宫颈癌正在成为全球女性发病率和死亡率上升的主要原因。 Toll 样受体(TLR)基因多态性可能导致癌症易感性的个体间差异。本研究旨在确定 TLR3(c.1377C/T)[rs3775290]和 TLR9(G2848A)[rs352140]基因多态性在印度北部宫颈癌发病风险中的作用。采集了 200 名经组织病理学证实的宫颈癌患者和 200 名来自印度北部、无癌、年龄匹配、具有相似种族背景的健康女性对照者的外周血样。采用盐析法提取基因组 DNA,采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)方法对 TLR3 和 TLR9 进行基因分型。我们的数据表明,TLR3(c.1377C/T)和 TLR9(G2848A)基因多态性与宫颈癌发病风险之间没有关联。TLR3 CT+TT 与宫颈癌易感性呈边缘相关(P=0.061;年龄校正 OR=1.46;95%CI=0.98-2.16)。TLR9 的 AA 基因型具有显著意义(P=0.053),提示其对晚期癌症(III+IV 期)具有边际增加的风险(OR=2.63,95%CI=0.99-7.01)。此外,TLR3 和 9 多态性在宫颈癌患者吸烟对风险的调节中没有显著作用。本研究表明,TLR3 和 9 基因多态性在印度北部宫颈癌易感性中仅起次要作用;然而,在不同种族人群中的进一步研究可能会提供更多有关先天免疫在全球女性宫颈癌发病机制中的综合作用。

相似文献

1
Evaluation of Toll-like receptors 3 (c.1377C/T) and 9 (G2848A) gene polymorphisms in cervical cancer susceptibility.评估 Toll 样受体 3(c.1377C/T)和 9(G2848A)基因多态性与宫颈癌易感性的关系。
Mol Biol Rep. 2011 Oct;38(7):4715-21. doi: 10.1007/s11033-010-0607-z. Epub 2010 Dec 5.
2
Evaluation of Toll-Like Receptors 2/3/4/9 Gene Polymorphisms in Cervical Cancer Evolution.宫颈癌进展中Toll样受体2/3/4/9基因多态性的评估
Pathol Oncol Res. 2016 Apr;22(2):323-30. doi: 10.1007/s12253-015-0009-6. Epub 2015 Nov 9.
3
Association of Toll-like receptor (TLR) 2, 3 and 9 genes polymorphism with prostate cancer risk in North Indian population.TLR2、3 和 9 基因多态性与印度北部人群前列腺癌风险的关联。
Mol Biol Rep. 2012 Jul;39(7):7263-9. doi: 10.1007/s11033-012-1556-5. Epub 2012 Feb 6.
4
Evaluation of neonatal Toll-like receptors 3 (c.1377C/T) and 9 (G2848A) gene polymorphisms in HBV intrauterine transmission susceptibility.新生儿Toll样受体3(c.1377C/T)和9(G2848A)基因多态性对HBV宫内传播易感性的评估
Epidemiol Infect. 2015 Jul;143(9):1868-75. doi: 10.1017/S0950268814002921. Epub 2014 Nov 12.
5
Involvement of Toll-like receptors in cervical cancer susceptibility among Tunisian women.Toll样受体在突尼斯女性宫颈癌易感性中的作用。
Bull Cancer. 2014 Oct;101(10):E31-5. doi: 10.1684/bdc.2014.2037.
6
Impact of Toll-like receptors [TLR] 2 (-196 to -174 del) and TLR 4 (Asp299Gly, Thr399Ile) in cervical cancer susceptibility in North Indian women.Toll样受体[TLR] 2(-196至-174缺失)和TLR 4(Asp299Gly、Thr399Ile)对北印度女性宫颈癌易感性的影响。
Gynecol Oncol. 2009 Sep;114(3):501-5. doi: 10.1016/j.ygyno.2009.05.032. Epub 2009 Jun 21.
7
Association of the polymorphism of the Toll-like receptor (TLR)-3 and TLR-9 genes with hepatitis C virus-specific cell-mediated immunity outcomes among Egyptian health-care workers.埃及医护人员 Toll 样受体(TLR)-3 和 TLR-9 基因多态性与丙型肝炎病毒特异性细胞免疫结果的关系。
Clin Exp Immunol. 2021 Jan;203(1):3-12. doi: 10.1111/cei.13514. Epub 2020 Oct 2.
8
Association of Toll-like receptor 3 and Toll-like receptor 9 single-nucleotide polymorphisms with hepatitis C virus persistence among Egyptians.埃及人中Toll样受体3和Toll样受体9单核苷酸多态性与丙型肝炎病毒持续感染的关联
Arch Virol. 2018 Sep;163(9):2433-2442. doi: 10.1007/s00705-018-3893-8. Epub 2018 Jun 2.
9
Cyclooxygenase-2 gene polymorphisms and risk of cervical cancer in a North Indian population.环氧化酶-2 基因多态性与印度北部人群宫颈癌风险的关系。
Int J Gynecol Cancer. 2010 May;20(4):625-30. doi: 10.1111/IGC.0b013e3181c63f79.
10
Association of toll-like receptor gene polymorphisms and its interaction with HPV infection in determining the susceptibility of cervical cancer in Chinese Han population.中国汉族人群中 Toll 样受体基因多态性及其与 HPV 感染的相互作用在决定宫颈癌易感性中的关联
Mamm Genome. 2017 Jun;28(5-6):213-219. doi: 10.1007/s00335-017-9691-x. Epub 2017 May 11.

引用本文的文献

1
Association of TLR3 1337C/T and 1234C/T polymorphisms with chronic hepatitis B virus infection in Sudanese patients: A case-control study.苏丹患者中TLR3 1337C/T和1234C/T基因多态性与慢性乙型肝炎病毒感染的关联:一项病例对照研究。
J Int Med Res. 2025 Jul;53(7):3000605251358062. doi: 10.1177/03000605251358062. Epub 2025 Jul 24.
2
Bioinformatics analysis to identify the relationship between human papillomavirus-associated cervical cancer, toll-like receptors and exomes: A genetic epidemiology study.基于外显子组的生物信息学分析鉴定人乳头瘤病毒相关宫颈癌、 toll 样受体与基因组的关系:一项遗传流行病学研究。
PLoS One. 2024 Aug 29;19(8):e0305760. doi: 10.1371/journal.pone.0305760. eCollection 2024.
3

本文引用的文献

1
Inhibition of ADP-ribosylation factor-like 6 interacting protein 1 suppresses proliferation and reduces tumor cell invasion in CaSki human cervical cancer cells.抑制 ADP-ribosylation 因子样蛋白 6 相互作用蛋白 1 可抑制 CaSki 人宫颈癌细胞的增殖并降低肿瘤细胞侵袭。
Mol Biol Rep. 2010 Dec;37(8):3819-25. doi: 10.1007/s11033-010-0037-y. Epub 2010 Mar 7.
2
Single-nucleotide polymorphisms in genes encoding toll-like receptor -2, -3, -4, and -9 in case-control study with breast cancer.乳腺癌病例对照研究中编码Toll样受体-2、-3、-4和-9的基因中的单核苷酸多态性
Genet Test Mol Biomarkers. 2009 Dec;13(6):729-34. doi: 10.1089/gtmb.2009.0045.
3
Genetic variation of TLR3 gene is associated with the outcome of hepatitis b infection in mauritanian patients: case control study.
TLR3 基因遗传变异与毛里塔尼亚患者乙型肝炎感染结局的相关性:病例对照研究。
BMC Infect Dis. 2024 Jun 21;24(1):616. doi: 10.1186/s12879-024-09503-w.
4
Recent advances in different interactions between toll-like receptors and hepatitis B infection: a review.近年来 Toll 样受体与乙型肝炎病毒感染相互作用的研究进展:综述。
Front Immunol. 2024 Mar 13;15:1363996. doi: 10.3389/fimmu.2024.1363996. eCollection 2024.
5
Safety, Efficacy, and Immunogenicity of Therapeutic Vaccines for Patients with High-Grade Cervical Intraepithelial Neoplasia (CIN 2/3) Associated with Human Papillomavirus: A Systematic Review.人乳头瘤病毒相关高级别宫颈上皮内瘤变(CIN 2/3)患者治疗性疫苗的安全性、有效性和免疫原性:一项系统评价
Cancers (Basel). 2024 Feb 5;16(3):672. doi: 10.3390/cancers16030672.
6
Association of IL-17A promoter region SNP-rs2275913 with urinary bladder cancer.白细胞介素-17A启动子区域单核苷酸多态性rs2275913与膀胱癌的关联
Int J Health Sci (Qassim). 2023 May-Jun;17(3):33-38.
7
Characterization of the microenvironment in different immune-metabolism subtypes of cervical cancer with prognostic significance.具有预后意义的宫颈癌不同免疫代谢亚型的微环境特征分析
Front Genet. 2023 Feb 3;14:1067666. doi: 10.3389/fgene.2023.1067666. eCollection 2023.
8
Association of toll-like receptors single nucleotide polymorphisms with HBV and HCV infection: research status.TLR 单核苷酸多态性与乙型肝炎病毒和丙型肝炎病毒感染的相关性:研究现状。
PeerJ. 2022 Apr 19;10:e13335. doi: 10.7717/peerj.13335. eCollection 2022.
9
HPV and the Risk of HIV Acquisition in Women.HPV 与女性 HIV 感染风险。
Front Cell Infect Microbiol. 2022 Feb 10;12:814948. doi: 10.3389/fcimb.2022.814948. eCollection 2022.
10
A Meta-Analysis for Association of XRCC3 rs861539, MTHFR rs1801133, IL-6 rs1800795, IL-12B rs3212227, TNF-α rs1800629, and TLR9 rs352140 Polymorphisms with Susceptibility to Cervical Carcinoma.一项关于 XRCC3 rs861539、MTHFR rs1801133、IL-6 rs1800795、IL-12B rs3212227、TNF-α rs1800629 和 TLR9 rs352140 多态性与宫颈癌易感性关联的荟萃分析。
Asian Pac J Cancer Prev. 2021 Nov 1;22(11):3419-3431. doi: 10.31557/APJCP.2021.22.11.3419.
Polymorphisms and haplotypes in TLR9 and MYD88 are associated with the development of Hodgkin's lymphoma: a candidate-gene association study.
TLR9 和 MYD88 中的多态性和单倍型与霍奇金淋巴瘤的发展相关:候选基因关联研究。
J Hum Genet. 2009 Nov;54(11):655-9. doi: 10.1038/jhg.2009.90. Epub 2009 Sep 11.
4
Toll-like receptor 9 agonists up-regulates the expression of cyclooxygenase-2 via activation of NF-kappaB in prostate cancer cells.Toll 样受体 9 激动剂通过激活 NF-κB 上调前列腺癌细胞中环氧化酶-2 的表达。
Mol Biol Rep. 2010 Apr;37(4):1849-55. doi: 10.1007/s11033-009-9620-5. Epub 2009 Jul 19.
5
Impact of Toll-like receptors [TLR] 2 (-196 to -174 del) and TLR 4 (Asp299Gly, Thr399Ile) in cervical cancer susceptibility in North Indian women.Toll样受体[TLR] 2(-196至-174缺失)和TLR 4(Asp299Gly、Thr399Ile)对北印度女性宫颈癌易感性的影响。
Gynecol Oncol. 2009 Sep;114(3):501-5. doi: 10.1016/j.ygyno.2009.05.032. Epub 2009 Jun 21.
6
CD14-159C/T and TLR9-1237T/C polymorphisms are not associated with gastric cancer risk in Caucasian populations.CD14基因的159C/T多态性和TLR9基因的1237T/C多态性与白种人群患胃癌的风险无关。
Eur J Cancer Prev. 2009 Apr;18(2):117-9. doi: 10.1097/CEJ.0b013e3283101292.
7
Increased expression of Toll-like receptors 4 and 9 in human lung cancer.人肺癌中Toll样受体4和9的表达增加。
Mol Biol Rep. 2009 Jul;36(6):1475-81. doi: 10.1007/s11033-008-9338-9. Epub 2008 Sep 2.
8
Toll-like receptor polymorphisms and susceptibility to human disease.Toll样受体基因多态性与人类疾病易感性
Clin Sci (Lond). 2008 Mar;114(5):347-60. doi: 10.1042/CS20070214.
9
Poly I:C enhances cycloheximide-induced apoptosis of tumor cells through TLR3 pathway.聚肌胞苷酸通过Toll样受体3途径增强环己酰亚胺诱导的肿瘤细胞凋亡。
BMC Cancer. 2008 Jan 17;8:12. doi: 10.1186/1471-2407-8-12.
10
Polymorphisms in Toll-like receptor genes and risk of cancer.Toll样受体基因多态性与癌症风险
Oncogene. 2008 Jan 7;27(2):244-52. doi: 10.1038/sj.onc.1210912.